14-34462198-T-C

Variant summary

Our verdict is Uncertain significance. Variant got 0 ACMG points: 0P and 0B.

The NM_138288.4(SPTSSA):ā€‹c.10A>Gā€‹(p.Met4Val) variant causes a missense change. The variant allele was found at a frequency of 0.000136 in 1,527,968 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (ā˜…).

Frequency

Genomes: š‘“ 0.000053 ( 0 hom., cov: 29)
Exomes š‘“: 0.00015 ( 0 hom. )

Consequence

SPTSSA
NM_138288.4 missense

Scores

2
4
12

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 6.62
Variant links:
Genes affected
SPTSSA (HGNC:20361): (serine palmitoyltransferase small subunit A) Serine palmitoyltransferase (SPT; EC 2.3.1.50) catalyzes the first committed and rate-limiting step in sphingolipid biosynthesis. SSSPTA is a small SPT subunit that stimulates SPT activity and confers acyl-CoA preference to the SPT catalytic heterodimer of SPTLC1 (MIM 605712) and either SPTLC2 (MIM 605713) or SPTLC3 (MIM 611120) (Han et al., 2009 [PubMed 19416851]).[supplied by OMIM, Nov 2010]
EGLN3 (HGNC:14661): (egl-9 family hypoxia inducible factor 3) Enables peptidyl-proline 4-dioxygenase activity. Involved in several processes, including activation of cysteine-type endopeptidase activity involved in apoptotic process; peptidyl-proline hydroxylation to 4-hydroxy-L-proline; and response to hypoxia. Located in cytosol and nucleus. Implicated in renal cell carcinoma. Biomarker of clear cell renal cell carcinoma. [provided by Alliance of Genome Resources, Apr 2022]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 0 ACMG points.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
SPTSSANM_138288.4 linkuse as main transcriptc.10A>G p.Met4Val missense_variant 1/2 ENST00000298130.5 NP_612145.2

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
SPTSSAENST00000298130.5 linkuse as main transcriptc.10A>G p.Met4Val missense_variant 1/21 NM_138288.4 ENSP00000298130 P1
EGLN3ENST00000551935.5 linkuse as main transcriptn.59+518A>G intron_variant, non_coding_transcript_variant 4

Frequencies

GnomAD3 genomes
AF:
0.0000533
AC:
8
AN:
150094
Hom.:
0
Cov.:
29
show subpopulations
Gnomad AFR
AF:
0.00
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000119
Gnomad OTH
AF:
0.00
GnomAD3 exomes
AF:
0.0000789
AC:
16
AN:
202668
Hom.:
0
AF XY:
0.000107
AC XY:
12
AN XY:
112538
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.000152
Gnomad FIN exome
AF:
0.0000493
Gnomad NFE exome
AF:
0.000120
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.000145
AC:
200
AN:
1377766
Hom.:
0
Cov.:
30
AF XY:
0.000136
AC XY:
93
AN XY:
685680
show subpopulations
Gnomad4 AFR exome
AF:
0.0000358
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000735
Gnomad4 FIN exome
AF:
0.0000199
Gnomad4 NFE exome
AF:
0.000176
Gnomad4 OTH exome
AF:
0.0000724
GnomAD4 genome
AF:
0.0000533
AC:
8
AN:
150202
Hom.:
0
Cov.:
29
AF XY:
0.0000545
AC XY:
4
AN XY:
73350
show subpopulations
Gnomad4 AFR
AF:
0.00
Gnomad4 AMR
AF:
0.00
Gnomad4 ASJ
AF:
0.00
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.00
Gnomad4 FIN
AF:
0.00
Gnomad4 NFE
AF:
0.000119
Gnomad4 OTH
AF:
0.00
Alfa
AF:
0.0000587
Hom.:
0
ExAC
AF:
0.0000665
AC:
8

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsAug 02, 2021The c.10A>G (p.M4V) alteration is located in exon 1 (coding exon 1) of the SPTSSA gene. This alteration results from a A to G substitution at nucleotide position 10, causing the methionine (M) at amino acid position 4 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.13
BayesDel_addAF
Benign
-0.17
T
BayesDel_noAF
Benign
-0.23
CADD
Uncertain
23
DANN
Benign
0.97
DEOGEN2
Benign
0.078
T
Eigen
Benign
-0.13
Eigen_PC
Benign
-0.036
FATHMM_MKL
Uncertain
0.94
D
LIST_S2
Benign
0.48
T
M_CAP
Pathogenic
0.82
D
MetaRNN
Uncertain
0.50
D
MetaSVM
Benign
-0.78
T
MutationTaster
Benign
1.0
D
PrimateAI
Pathogenic
0.87
D
PROVEAN
Benign
-1.8
N
REVEL
Benign
0.26
Sift
Uncertain
0.010
D
Sift4G
Uncertain
0.041
D
Polyphen
0.0
B
Vest4
0.58
MutPred
0.41
Gain of catalytic residue at M4 (P = 0);
MVP
0.46
MPC
0.29
ClinPred
0.59
D
GERP RS
4.0
Varity_R
0.75
gMVP
0.92

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.090
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs200762762; hg19: chr14-34931404; API